3-(PYRIDIN-4-YL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE HCL, 95.0%, 250mg

Methylcyclohexane, min. 99%, for synthesis, 2.5 L, glass packaging

4-Bromo-5-methylpyrimidin-2-amine, 98+%, 1g

5-(aminomethyl)-2,4(1H,3H)-pyrimidinedione hydrochloride, 95.0%, 250mg

4-Chloropicolinaldehyde, 97.0%, 1g

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 45 mm, 1 Piece(s)

7-Bromoquinazoline, 95.0%, 250mg

N-[(1-Adamantylamino)carbonyl]glycine, 95.0%, 1g

(S)-3-Amino-2-hydroxypropanoic acid, 95.0%, 25g

Dimethyl 2-ethylidenemalonate, 95.0%, 250mg

1-(2-BROMO-5-HYDROXYPHENYL)ETHANONE, 95.0%, 1g

1,2-Bis(1,1,2,2-tetrafluoroethoxy)benzene, 97.0%, 100g

5-Bromo-4-chloro-2-fluorobenzoic acid, 95.0%, 5g